Company Name: Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The company is engaged in the development of adeno-associated virus (AAV) gene therapies designed to treat central nervous system disorders. The company’s pipeline includes product candidates for:
Ticker Symbol: VYGR (NASDAQ)
Company Website: www.voyagertherapeutics.com
Social Media: Voyager Therapeutics LinkedIn
Headquarters: Cambridge, MA